Empagliflozin compared with glimepiride in metformin‐treated patients with type 2 diabetes: 208‐week data from a masked randomized controlled trial
Year: 2018
Type: article
Study design: Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.13457
Authors: Martin Ridderstråle, Julio Rosenstock, Knut R. Andersen, Hans J. Woerle, Afshin Salsali, on behalf of the EMPA‐REG H2H‐SU trial investigators
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G6433152044
OpenAlex ID: W2809903778
